Enlivex Ltd. (ENLV)
0.2599
-0.02
(-6.17%)
USD |
NASDAQ |
Oct 09, 16:00
0.255
0.00 (0.00%)
After-Hours: 16:51
Enlivex Total Liabilities (Quarterly) : 1.002B for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.002B |
| December 31, 2025 | 392.05M |
| September 30, 2025 | 3.457M |
| June 30, 2025 | 3.544M |
| March 31, 2025 | 3.408M |
| December 31, 2024 | 4.098M |
| September 30, 2024 | 3.21M |
| June 30, 2024 | 3.34M |
| March 31, 2024 | 4.196M |
| December 31, 2023 | 6.747M |
| September 30, 2023 | 8.157M |
| June 30, 2023 | 8.693M |
| March 31, 2023 | 9.448M |
| December 31, 2022 | 10.80M |
| September 30, 2022 | 9.14M |
| June 30, 2022 | 8.855M |
| March 31, 2022 | 10.97M |
| December 31, 2021 | 10.11M |
| September 30, 2021 | 10.08M |
| June 30, 2021 | 4.981M |
| March 31, 2021 | 5.357M |
| December 31, 2020 | 4.871M |
| September 30, 2020 | 4.873M |
| June 30, 2020 | 5.245M |
| March 31, 2020 | 5.592M |
| Date | Value |
|---|---|
| December 31, 2019 | 6.278M |
| September 30, 2019 | 5.434M |
| June 30, 2019 | 5.468M |
| March 31, 2019 | 5.59M |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | 0.46M |
| September 30, 2017 | 0.537M |
| June 30, 2017 | 0.792M |
| March 31, 2017 | 1.618M |
| December 31, 2016 | 1.931M |
| September 30, 2016 | 1.999M |
| June 30, 2016 | 1.468M |
| March 31, 2016 | 2.30M |
| December 31, 2015 | 2.584M |
| September 30, 2015 | 1.813M |
| June 30, 2015 | 1.768M |
| March 31, 2015 | 1.752M |
| December 31, 2014 | 2.28M |
| September 30, 2014 | 1.146M |
| June 30, 2014 | 0.715M |
| March 31, 2014 | |
| December 31, 2013 | 0.131M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Polyrizon Ltd. | -- |
| NovelStem International Corp. | 2.097M |
| Brainstorm Cell Therapeutics, Inc. | 12.38M |
| Summit Therapeutics, Inc. | 122.20M |
| PeptiDream Inc. | 145.64M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.900B |
| Shareholders Equity (Quarterly) | 3.898B |
| Debt to Equity Ratio | 0.0045 |
| Current Ratio | 119.39 |
| Net Debt Paydown Yield | -2.45% |